Jennifer Johnston

Jennifer Johnston

Company: NysnoBio

Job title: Chief Executive Officer


Therapeutic Approaches to Targeting Parkin E3 Ub Ligase 12:00 pm

Parkin Ligase regulates pathways critical to cellular health and is highly validated target Small Molecule Drug Discovery has revealed significant challenges for Parkin Detailed understanding of Parkin enzymology and biology is critical for Drug DevelopmentRead more

day: Focus Day

Roundtable Session: Tissue & Cell Selectivity – Highlighting the Potential for Selective E3 Targeting 2:30 pm

As expression and profiling data begin to shed light on the distribution of E3’s across cell and tissue types, it is becoming evident that such data may provide promising insights to aid the development of tissue E3 specific targeting, within a therapeutic context. What is the difficulty of selectively targeting E3’s in tumor cells and…Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.